Literature DB >> 17785771

Cutting edge: syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity.

Laura N Arneson1, Adipong Brickshawana, Colin M Segovis, Renee A Schoon, Christopher J Dick, Paul J Leibson.   

Abstract

Little is known about the regulatory roles of specific soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins in cytotoxic lymphocytes. Recent information suggests that mutations in the SNARE protein syntaxin 11 result in a form of familial hemophagocytic lymphohistiocytosis (FHL). Because genetic abnormalities in key granule components (e.g., perforin) or in regulators of secretion (e.g., Munc13-4) underlie the other identified forms of FHL, we assessed whether syntaxin 11 might also serve a related regulatory role. We determined that syntaxin 11 is expressed in NK cells and activated CTLs and is located in discrete membrane-associated structures in the cytoplasm. Enhanced expression of syntaxin 11 augments the secretion and killing of tumor targets, and suppression of syntaxin 11 expression inhibits these functions. Our data identify and characterize a role for syntaxin 11 in granule exocytosis and in the generation of cell-mediated killing. These results also provide new insights on the mechanisms of hemopoietic dysregulation in FHL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785771     DOI: 10.4049/jimmunol.179.6.3397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Line of attack: NK cell specificity and integration of signals.

Authors:  Yenan T Bryceson; Eric O Long
Journal:  Curr Opin Immunol       Date:  2008-04-23       Impact factor: 7.486

Review 2.  Natural killer cell cytotoxicity: how do they pull the trigger?

Authors:  Nicola J Topham; Eric W Hewitt
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

3.  Cytotoxic T lymphocyte effector function is independent of nucleus-centrosome dissociation.

Authors:  Winnie W Y Lui-Roberts; Jane C Stinchcombe; Alex T Ritter; Anna Akhmanova; Iakowos Karakesisoglou; Gillian M Griffiths
Journal:  Eur J Immunol       Date:  2012-08       Impact factor: 5.532

Review 4.  The biogenesis of lysosomes and lysosome-related organelles.

Authors:  J Paul Luzio; Yvonne Hackmann; Nele M G Dieckmann; Gillian M Griffiths
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-02       Impact factor: 10.005

Review 5.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

Review 6.  Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.

Authors:  Prasad V Phatarpekar; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2020-02-21       Impact factor: 5.285

Review 7.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

8.  Novel syntaxin 11 gene (STX11) mutation in three Argentinean patients with hemophagocytic lymphohistiocytosis.

Authors:  Silvia Danielian; Natalia Basile; Carlos Rocco; Emma Prieto; Jorge Rossi; Darío Barsotti; Paul A Roche; Andrea Bernasconi; Matías Oleastro; Marta Zelazko; Jorge Braier
Journal:  J Clin Immunol       Date:  2009-12-05       Impact factor: 8.317

9.  Dynamin 2 regulates granule exocytosis during NK cell-mediated cytotoxicity.

Authors:  Laura N Arneson; Colin M Segovis; Timothy S Gomez; Renee A Schoon; Christopher J Dick; Zhenkun Lou; Daniel D Billadeau; Paul J Leibson
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation.

Authors:  Orietta D'Orlando; Fang Zhao; Brigitte Kasper; Zane Orinska; Jürgen Müller; Irm Hermans-Borgmeyer; Gillian M Griffiths; Udo Zur Stadt; Silvia Bulfone-Paus
Journal:  Eur J Immunol       Date:  2012-12-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.